These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22310855)

  • 1. Adverse events in nuclear medicine - cause for concern?
    Hesse B; Vinberg N; Berthelsen AK; Ballinger JR
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):782-5. PubMed ID: 22310855
    [No Abstract]   [Full Text] [Related]  

  • 2. Breastfeeding and radiologic procedures.
    Newman J
    Can Fam Physician; 2007 Apr; 53(4):630-1. PubMed ID: 17872711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further considerations on adverse reactions to radiopharmaceuticals.
    Salvatori M; Treglia G; Mores N
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1360-2. PubMed ID: 22526962
    [No Abstract]   [Full Text] [Related]  

  • 4. [The 27th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 30th survey in 2004)].
    Kusakabe K; Okamura T; Kasagi K; Komatani A; Sato Y; Matsuda H; Maruno H; ;
    Kaku Igaku; 2006 Feb; 43(1):23-35. PubMed ID: 16634540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is medical imaging iatrogenic?].
    Morvan G
    Bull Acad Natl Med; 2014; 198(4-5):725-40; discussion 741-3. PubMed ID: 26753405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation Exposure in Imaging of Suspected Child Abuse: Benefits versus Risks.
    Slovis TL; Strouse PJ; Strauss KJ
    J Pediatr; 2015 Nov; 167(5):963-8. PubMed ID: 26354874
    [No Abstract]   [Full Text] [Related]  

  • 7. Gadolinium- or iodine-based contrast media: which choice?
    Thomsen HS
    Acta Radiol; 2014 Sep; 55(7):771-5. PubMed ID: 25138436
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic tools and therapeutic interventions that may influence the integrity of vascular and nonvascular access devices.
    Earhart A
    J Infus Nurs; 2005; 28(3 Suppl):S13-7; quiz S33-6. PubMed ID: 15965375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic cross-sectional imaging of arterial diseases: really noninvasive?
    Laissy JP; Pasi N; Serfaty JM
    Eur Radiol; 2011 Mar; 21(3):559-61. PubMed ID: 21076960
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent hot topics in contrast media.
    Thomsen HS
    Eur Radiol; 2011 Mar; 21(3):492-5. PubMed ID: 21136062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A doctor talks about radiation risk from medical imaging.
    Robb-Nicholson C
    Harv Womens Health Watch; 2010 Oct; 18(2):4-5. PubMed ID: 21268315
    [No Abstract]   [Full Text] [Related]  

  • 12. Australian per caput dose from diagnostic imaging and nuclear medicine.
    Hayton A; Wallace A; Marks P; Edmonds K; Tingey D; Johnston P
    Radiat Prot Dosimetry; 2013 Oct; 156(4):445-50. PubMed ID: 23604741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk-group patients due to the administration of iodine and gadolinium preparations for diagnostic clinical study].
    Napolov IuK; Korobkova IZ; Maslennikov MA
    Vestn Rentgenol Radiol; 2011; (1):29-40. PubMed ID: 21598470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR imaging.
    Halvorsen RA
    Radiology; 2008 Oct; 249(1):9-15. PubMed ID: 18796664
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiation dose in nuclear medicine: the hybrid imaging.
    Salvatori M; Rizzo A; Rovera G; Indovina L; Schillaci O
    Radiol Med; 2019 Aug; 124(8):768-776. PubMed ID: 30771217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global contrast in nuclear medicine.
    Currie GM; Kiat H; Wheat JM
    J Nucl Med Technol; 2010 Sep; 38(3):115-6. PubMed ID: 20807852
    [No Abstract]   [Full Text] [Related]  

  • 17. Contrast-induced nephropathy: back to basics.
    Boccalandro F; Anderson HV
    J Invasive Cardiol; 2003 Jun; 15(6):317-8. PubMed ID: 12777669
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine.
    Silberstein EB; Ryan J
    J Nucl Med; 1996 Jan; 37(1):185-92. PubMed ID: 8543992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project.
    Cutler CS; Bailey E; Kumar V; Schwarz SW; Bom HS; Hatazawa J; Paez D; Orellana P; Louw L; Mut F; Kato H; Chiti A; Frangos S; Fahey F; Dillehay G; Oh SJ; Lee DS; Lee ST; Nunez-Miller R; Bandhopadhyaya G; Pradhan PK; Scott AM
    J Nucl Med; 2021 Mar; 62(3):422-430. PubMed ID: 32646881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of radiocontrast-induced nephropathy.
    Baker CS
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):532-8. PubMed ID: 12652507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.